American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

InMed Pharmaceuticals Inc. (INM)

$1.59 +0.00% NASDAQ: INM · 15-min delayed

VANCOUVER, A1
Public · NASDAQ: INM
13 employees

Visit website Follow

$9.1MMarket cap

$4.9MRevenue · FY2025

-$8.2MNet income

13Employees

INMNASDAQ

2020IPO

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: INM
Employees: 13
IPO date: Nov 10, 2020
Headquarters: 1445-885 WEST GEORGIA ST.
VANCOUVER, A1 V6C 3E8
Phone: (604) 669-7207
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: INM Nasdaq
SEC CIK: 1728328
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show InMed Pharmaceuticals Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/inmed-pharmaceuticals-inc/"><img src="https://americancompanies.com/badge/inmed-pharmaceuticals-inc.svg" alt="InMed Pharmaceuticals Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow InMed Pharmaceuticals Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $4.9M
Net income: -$8.2M
Total assets: $15.6M
Market cap: $9.1M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: INM

$1.59 +0.00%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.62 $2.46

52-week range

Market cap: $9.1M
Shares outstanding: 5.7M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Nov 10, 2020

InMed Pharmaceuticals Inc. (INM) Stock Price

Reported a net loss of $8.2M in FY2025.
Trading 35% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review InMed Pharmaceuticals Inc..

Write a review

Newsroom

News about InMed Pharmaceuticals Inc.

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM) GlobeNewswire Inc. · 2026-05-19 · negative InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying Benzinga · 2024-02-23 Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying Benzinga · 2024-02-22 Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket Benzinga · 2023-12-21 Investment Chief At $48B Global X Forecasts AI Stock Dominance In 2024: Unveils Top Investment Opportunities Benzinga · 2023-12-18 Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Benzinga · 2023-10-25

News & sentiment via Polygon.io

FAQ

InMed Pharmaceuticals Inc.: frequently asked questions

Is InMed Pharmaceuticals Inc. an American company?

InMed Pharmaceuticals Inc. is a US-based company headquartered in Vancouver, A1, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is InMed Pharmaceuticals Inc. headquartered?

InMed Pharmaceuticals Inc. is headquartered in Vancouver, A1, United States.

Is InMed Pharmaceuticals Inc. publicly traded?

Yes — InMed Pharmaceuticals Inc. is a publicly traded company. Its stock trades under the ticker symbol INM on the NASDAQ.

What does InMed Pharmaceuticals Inc. do?

InMed Pharmaceuticals Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore